Veracyte, Inc.
Status: Publicly traded
Direct answer
Veracyte, Inc. is publicly traded on NASDAQ under the ticker VCYT.
Veracyte, Inc. operates as a global diagnostics company, specializing in the development and commercialization of advanced genomic tests. The company's product portfolio encompasses several key diagnostic solutions: The Afirma Genomic Sequencing Classifier and Xpression Atlas, which help patients with indeterminate thyroid nodule results avoid unnecessary surgical procedures by identifying benign cases. Decipher...
Can you invest in Veracyte, Inc.?
Yes. Veracyte, Inc. is publicly traded on NASDAQ under the ticker VCYT.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Veracyte, Inc.
Detailed equity research is provided by MarketSnap.